Shareholders' equity · 2018–2025

Beam Therapeutics shareholders' equity

$1.2B+68.8% · FY2025

Beam Therapeutics (BEAM) reported $1.2B in shareholders' equity for fiscal 2025, +68.8% year on year.

−$117M2018−$201M2019$246M2020$827M2021$733M2022$981M2023$734M2024$1.2B2025
Beam Therapeutics — Shareholders' equity, 2018–2025
Fiscal yearShareholders' equityChangeFiling
FY20252025-12-31$1.2B+68.8%Open →
FY20242024-12-31$734M−25.2%Open →
FY20232023-12-31$981M+33.8%Open →
FY20222022-12-31$733M−11.3%Open →
FY20212021-12-31$827M+236.7%Open →
FY20202020-12-31$246M+$447MOpen →
FY20192019-12-31−$201M−$83.7MOpen →
FY20182018-12-31−$117M—Open →

Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Shareholders' equity at companies of similar size

Full ranking by shareholders' equity →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Beam Therapeutics shareholders' equity |url=https://companiesranked.com/en/company/beam-therapeutics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Beam Therapeutics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/beam-therapeutics/shareholders-equity

BibTeX

@misc{companiesranked-en-company-beam-therapeutics-shareholders-equity-2026,
  author       = {{CompaniesRanked}},
  title        = {{Beam Therapeutics shareholders' equity}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/beam-therapeutics/shareholders-equity}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001193125-26-331541 · August 4, 2026

{{cite web |title=Beam Therapeutics shareholders' equity — 10-Q (0001193125-26-331541) |url=https://www.sec.gov/Archives/edgar/data/1745999/000119312526331541/beam-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Beam Therapeutics overview